SS-31 Inhibits the Inflammatory Response by Increasing ATG5 and Promoting Autophagy in Lipopolysaccharide-Stimulated HepG2 Cells

Yunan Mo,Songyun Deng,Yuhang Ai,Wenchao Li
DOI: https://doi.org/10.1016/j.bbrc.2024.149887
IF: 3.1
2024-01-01
Biochemical and Biophysical Research Communications
Abstract:SS-31 is a mitochondria-targeting short peptide. Recent studies have indicated its hepatoprotective effects. In our study, we investigated the impact of SS-31 on LPS-induced autophagy in HepG2 cells. The results obtained from a dual-fluorescence autophagy detection system revealed that SS-31 promotes the formation of autolysosomes and autophagosomes, thereby facilitating autophagic flux to a certain degree. Additionally, both ELISA and qPCR analyses provided further evidence that SS-31 safeguards HepG2 cells against inflammatory responses triggered by LPS through ATG5-dependent autophagy. In summary, our study demonstrates that SS-31 inhibits LPS-stimulated inflammation in HepG2 cells by upregulating ATG5-dependent autophagy.
What problem does this paper attempt to address?